Yes, PCYC has a very impressive BTK inhibitor. But is the company really worth $1.7B? The cmpd is in Ph2/3 and the Co has no revenue. What biotech company w/ a similar profile has such a market cap?
Sooner or later you"ll pay the price just to cover your short position...Good Luck and DD always pays
Nothing but hype!